Literature DB >> 26392361

Reproductive Decision-Making in MMR Mutation Carriers After Results Disclosure: Impact of Psychological Status in Childbearing Options.

Jacqueline Duffour1,2, Audrey Combes3,4, Evelyne Crapez5, Florence Boissière-Michot6, Frédéric Bibeau6, Pierre Senesse7, Marc Ychou8, Julie Courraud9, Hélène de Forges9, Lise Roca10.   

Abstract

Reproductive techniques such as prenatal diagnosis (PND) or preimplantation genetic diagnosis (PGD), although debated, are legally forbidden in France in case of Lynch syndrome. The preference of mutation carriers about their reproductive options is not systematically considered in France. We aimed to prospectively assess the reproductive preferences of mismatch repair mutation carriers consulting in our institution (2003-2010, n = 100). We also considered the short- and long-term post-disclosure psychological impact using the Impact of Events Scale-Revised questionnaire to measure the prevalence of posttraumatic stress disorder (PTSD) in those patients. Complete data were obtained for 34 respondents (17 males, 17 females, median age of 33.5 years [22-59]). Seventeen respondents (57 %) preferred spontaneous natural conception versus 28 % and 35 % choosing PND and PGD, respectively. At results disclosure, respondents mainly explained their distress by fear of premature death (43 %) and transmitting mutated genes (42 %). One year later, this last fear remained predominant in 55 % of subjects. None of the main socio-demographical, psychological or medical variables (including fear of transmitting mutations) was significantly associated with the reproductive preferences. Results disclosure had a real and time-decreasing psychological impact on mutation carriers. Reproductive techniques, expected to decrease the hereditary risk, were not significantly preferred to natural conception.

Entities:  

Keywords:  Colorectal neoplasms; Genetic carrier detection; Hereditary non-polyposis; Mutation; Post-traumatic stress disorders; Preimplantation genetic diagnosis; Prenatal diagnosis

Mesh:

Year:  2015        PMID: 26392361     DOI: 10.1007/s10897-015-9888-7

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  38 in total

1.  Preimplantation diagnosis for genetic susceptibility.

Authors:  Peter Braude
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

2.  Reducing the risk of gynecologic cancer in the Lynch syndrome.

Authors:  Kenneth Offit; Noah D Kauff
Journal:  N Engl J Med       Date:  2006-01-19       Impact factor: 91.245

3.  Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch syndrome.

Authors:  Akriti Dewanwala; Anu Chittenden; Margery Rosenblatt; Rowena Mercado; Judy E Garber; Sapna Syngal; Elena M Stoffel
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

4.  Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study.

Authors:  K Aktan-Collan; A Haukkala; J P Mecklin; A Uutela; H Kääriäinen
Journal:  Int J Cancer       Date:  2001-08-15       Impact factor: 7.396

5.  Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.

Authors:  Ellen R Gritz; Susan K Peterson; Sally W Vernon; Salma K Marani; Walter F Baile; Beatty G Watts; Christopher I Amos; Marsha L Frazier; Patrick M Lynch
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

6.  Much more than a gene: hereditary breast and ovarian cancer, reproductive choices and family life.

Authors:  Catherine Dekeuwer; Simone Bateman
Journal:  Med Health Care Philos       Date:  2013-05

7.  Patient vs. physician as the target of educational outreach about screening for an inherited susceptibility to colorectal cancer.

Authors:  Starlene Loader; Cleveland Shields; Jeffrey C Levenkron; Richard Fishel; Peter T Rowley
Journal:  Genet Test       Date:  2002

8.  Living with hereditary non-polyposis colorectal cancer; experiences from and impact of genetic testing.

Authors:  C Carlsson; M Nilbert
Journal:  J Genet Couns       Date:  2007-08-18       Impact factor: 2.537

9.  The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome.

Authors:  Patrice Watson; Hans F A Vasen; Jukka-Pekka Mecklin; Inge Bernstein; Markku Aarnio; Heikki J Järvinen; Torben Myrhøj; Lone Sunde; Juul T Wijnen; Henry T Lynch
Journal:  Int J Cancer       Date:  2008-07-15       Impact factor: 7.396

10.  Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

Authors:  H F Vasen; J T Wijnen; F H Menko; J H Kleibeuker; B G Taal; G Griffioen; F M Nagengast; E H Meijers-Heijboer; L Bertario; L Varesco; M L Bisgaard; J Mohr; R Fodde; P M Khan
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.